NCT Number: NCT03450577
The IBS registry is an observational, multi-center, real-world registry of stenting in coronary bifurcation lesions that will collect information on procedures and outcomes from various participating centers.
The aim of this registry is to investigate long-term clinical results and predictors of adverse outcomes after PCI for coronary bifurcation lesions among various participating centers.
Interested in participating?
Request Info18 year–100 year
All sexes
Observational
Novosibirsk, Novosibirsk Oblast, 630055, Russia
Location status: Recruiting
Aram Badoyan, MD
CONTACT
Aram Badoyan, MD
SUB_INVESTIGATOR
Dmitrii Khelimskii, MD
CONTACT
Dmitrii Khelimskii, MD
PRINCIPAL_INVESTIGATOR
Oleg Krestyaninov, MD, PhD
SUB_INVESTIGATOR
Patients with coronary bifurcation lesions, if they meets all the study inclusion criteria and none of the exclusion criteria, after signing the informed consent, they will underwent PCI according to the current standard of care and will be entered in the registry. Follow-up for all subjects will continue for 5 years.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Different approaches for treatment of bifurcation coronary artery disease.
Time frame: 1 day
Achievement of technical success and with no in-hospital major adverse cardiac events
Time frame: 6 months, 1 year, 3 years, 5 years
Death, myocardial infarction (MI), target vessel revascularization (TVR), or stroke.
Time frame: 6 months, 1 year, 3 years, 5 years
All of the deaths that occur in a study group, regardless of the cause.
Time frame: 6 months, 1 year, 3 years, 5 years
All deaths will be assumed cardiovascular in nature unless a non-cardiovascular cause can be clearly provided (e.g. malignancy, trauma, and infection).
Time frame: 6 months, 1 year, 3 years, 5 years
The presence of electrocardiography findings indicative of ischemia that were not related to the index procedure, as well as chest discomfort associated with creatinine kinase-myocardial band fraction or troponin-T/troponin I greater than the upper limit of normal.
Time frame: 6 months, 1 year, 3 years, 5 years
Repeat PCI of the lesion within 5 mm of stent deployment or bypass graft surgery of the target vessel.
Time frame: 6 months, 1 year, 3 years, 5 years
Sudden occlusion of a stented coronary artery due to formation of thrombosis.According to the Academic Research Consortium was defined as definite, probable, or possible.
Contact information is provided by the study sponsor or research team.
Meshalkin Research Institute of Pathology of Circulation
Network
International Prospective Register on Treatment of Coronary Artery Bifurcation Lesions
Acronym: IBS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07711106
Arterial Occlusive Diseases, Arteriosclerosis
Saint Petersburg, Russia
View Trial DetailsNCT07596706
Arterial Occlusive Diseases, Arteriosclerosis
Istanbul, Please Select, Turkey (Türkiye)
View Trial DetailsNCT06618248
Coronary Bifurcation Lesion
Beijing, Beijing Municipality, China
View Trial DetailsNCT05731687
Arterial Occlusive Diseases, Arteriosclerosis
Eindhoven, North Brabant, Netherlands
View Trial Details